Using observational data for personalized medicine when clinical trial evidence is limited

Area of Science:

• Epidemiology
• Biostatistics
• Health Services Research

Background:

• Randomized clinical trials (RCTs) are the gold standard for treatment comparison.
• High-quality RCT data is often unavailable for many clinical questions.
• Clinical decisions frequently rely on observational studies.

Purpose of the Study:

• To discuss using observational data and modern epidemiological/statistical methods to assess intervention effects.
• To address situations where RCT evidence is unavailable or not applicable to the target population.
• To explore pathways toward personalized medicine using advanced analytical techniques.

Main Methods:

• Emulating hypothetical pragmatic target trials using observational data.
• Transporting inferences from existing trial data to target populations using observational data.
• Analyzing heterogeneity of treatment effects.

Main Results:

• Observational data, when analyzed with modern methods, can effectively emulate RCTs.
• Inferences from trials can be generalized to broader populations.
• These methods facilitate understanding treatment effects in real-world settings.

Conclusions:

• Observational data analysis, including trial emulation and transportability, offers a viable alternative when RCTs are limited.
• These approaches support evidence-based clinical decision-making and personalized medicine.
• Combining trial emulation with transportability analysis enhances the utility of available evidence.